Key result
Peripheral endothelial dysfunction was present in 77.2% of patients with type 2 diabetes and CAD, with plasma cholesterol (OR 4.083; 95% CI 1.080-17.017) and age identified as key determinants.
Why the study?
What clinical and metabolic factors correlate with ultrasound-measured peripheral endothelial dysfunction in patients with type 2 diabetes and coronary artery disease?
Cross-Sectional (n=171)
What clinical and metabolic factors correlate with ultrasound-measured peripheral endothelial dysfunction in patients with type 2 diabetes and coronary artery disease?
Effect estimate: OR 4.083 (95% CI 1.080-17.017)
Endothelial dysfunction prevalent and linked to cholesterol/age in T2D-CAD; hypothesis-generating, prospective studies needed before clinical adoption.
The purpose of the study was to assess the endothelial dysfunction (ED) in type 2 diabetic patients ultrasonographically and estimate the correlation of ED with glycemia and other cardio-metabolic risk factors. 171 patient (age 60.0 + 8.5 years) with diagnosed type 2 diabetes and coronary artery disease (CAD) were randomly included in a cross sectional study. B-mode ultrasound system with a linear transducer of 7.5 MHz was used for evaluation of flow-mediated vasodilation in brachial artery (FMV). FMV was presented as a change of brachial artery diameter at rest and after limb ischemia, previously provoked by cuff inflation. Peripheral ED was found in 77.2% (132 patients). Multivariate logistic regression model defined: age (OR 1.071, 95% CI 1.003 1,143) and plasma cholesterol (OR 4.083 95% CI 1.080 17,017) as determinants for ED. Linear multivariate analysis presented duration of diabetes (Beta 0.173, Sig 0.024), and glycemia (Beta 0.132, Sig 0.044) to be associated independently with FMV value. Estimated factors influencing FMV, might be potential therapeutic targets for presented endothelial dysfunction in type 2 diabetic patients with coronary artery disease.
No takes yet. Share an insight, caveat, or question.
Bosevski et al. (2010) conducted a cross-sectional in Type 2 diabetes and coronary artery disease (n=171). Risk factor assessment was evaluated on Peripheral endothelial dysfunction (ED) (OR 4.083, 95% CI 1.080-17.017). Peripheral endothelial dysfunction was present in 77.2% of patients with type 2 diabetes and CAD, with plasma cholesterol (OR 4.083; 95% CI 1.080-17.017) and age identified as key determinants.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: